Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

VOXIMED : revenue, balance sheet and financial ratios

VOXIMED is a French company founded 4 years ago, specialized in the sector Activités de centres d'appels. Based in LYON (69002), this company of category PME shows in 2024 a net income positive of 78 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - VOXIMED (SIREN 908455496)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income 78 184 € 21 995 € -28 074 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2024, VOXIMED generates positive net income of 78 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

78 184 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 81%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 20%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

81.181%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

19.742%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

51.4%

Solvency indicators evolution
VOXIMED

Sector positioning

Debt ratio
81.18 2024
2022
2023
2024
Q1: 0.0
Med: 0.61
Q3: 32.15
Watch +52 pts over 3 years

In 2024, the debt ratio of VOXIMED (81.18) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
19.74% 2024
2022
2023
2024
Q1: 5.44%
Med: 27.68%
Q3: 50.14%
Average +16 pts over 3 years

In 2024, the financial autonomy of VOXIMED (19.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 122.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

122.521

Liquidity indicators evolution
VOXIMED

Sector positioning

Liquidity ratio
122.52 2024
2022
2023
2024
Q1: 102.55
Med: 152.5
Q3: 216.39
Average +6 pts over 3 years

In 2024, the liquidity ratio of VOXIMED (122.52) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of VOXIMED in its sector

Comparison with sector Activités de centres d'appels

Valuation estimate

Based on 447 transactions of similar company sales (all years), the value of VOXIMED is estimated at 251 647 € (range 81 363€ - 657 776€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
447 transactions
81k€ 251k€ 657k€
251 647 € Range: 81 363€ - 657 776€
Section all-time Aggregated at NAF section level

Valuation method used

Net Income Multiple
78 184 € × 3.2x = 251 648 €
Range: 81 363€ - 657 777€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 447 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités de centres d'appels)

Compare VOXIMED with other companies in the same sector:

Frequently asked questions about VOXIMED

What is the revenue of VOXIMED ?

The revenue of VOXIMED is not publicly disclosed (confidential accounts filed with INPI).

Is VOXIMED profitable?

Yes, VOXIMED generated a net profit of 78 k€ in 2024.

Where is the headquarters of VOXIMED ?

The headquarters of VOXIMED is located in LYON (69002), in the department Rhone.

Where to find the tax return of VOXIMED ?

The tax return of VOXIMED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does VOXIMED operate?

VOXIMED operates in the sector Activités de centres d'appels (NAF code 82.20Z). See the 'Sector positioning' section above to compare the company with its competitors.